Systematic review of economic evaluations for paediatric pulmonary diseases

Simple item page
dc.contributor.advisorCunnama, Lucy
dc.contributor.authorChitando, Mutsawashe
dc.date.accessioned2021-07-12T17:20:21Z
dc.date.available2021-07-12T17:20:21Z
dc.date.issued2021
dc.date.updated2021-07-12T17:18:42Z
dc.description.abstractBackground Pulmonary diseases are the leading causes of mortality globally amongst children under five years of age. Economic evaluations (EEs) guide decision-makers on which health care intervention to adopt to reduce paediatric pulmonary disease burden. Methods We systematically reviewed EEs for paediatric pulmonary diseases published globally between 2010 and 2020. We searched PubMed, Web of Science, MEDLINE, Paediatric Economic Database Evaluation (PEDE), and the Cochrane library. EEs included were specific to paediatric pulmonary diseases in a hospital setting and of children aged from zero to six years old. We extracted data items guided by the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. We collected qualitative and quantitative data which we analysed in Microsoft Excel and R Software. Results 22 studies met the inclusion criteria. Seven of the articles were cost-effectiveness analyses, five cost-utility analyses, two cost-minimisation analyses, and eight cost analyses. Fourteen studies were conducted in high-income countries, eight in low-middle-income countries (LMICs). Ten studies were on asthma, nine on pneumonia, two on asthma and pneumonia, and one on tuberculosis. Quality assessment of the articles revealed some methodological inconsistencies across the articles. Conclusion Fewer EEs were conducted in LMICs, yet children from these countries are disproportionately affected by pulmonary diseases. Developing standardised methods for EEs and conducting more EEs and for paediatric pulmonary diseases in LMICs could allow for more evidence-based decision-making.
dc.identifier.apacitationChitando, M. (2021). <i>Systematic review of economic evaluations for paediatric pulmonary diseases</i>. (). ,Faculty of Health Sciences ,Health Economics Unit. Retrieved from http://hdl.handle.net/11427/33600en_ZA
dc.identifier.chicagocitationChitando, Mutsawashe. <i>"Systematic review of economic evaluations for paediatric pulmonary diseases."</i> ., ,Faculty of Health Sciences ,Health Economics Unit, 2021. http://hdl.handle.net/11427/33600en_ZA
dc.identifier.citationChitando, M. 2021. Systematic review of economic evaluations for paediatric pulmonary diseases. . ,Faculty of Health Sciences ,Health Economics Unit. http://hdl.handle.net/11427/33600en_ZA
dc.identifier.ris TY - Master Thesis AU - Chitando, Mutsawashe AB - Background Pulmonary diseases are the leading causes of mortality globally amongst children under five years of age. Economic evaluations (EEs) guide decision-makers on which health care intervention to adopt to reduce paediatric pulmonary disease burden. Methods We systematically reviewed EEs for paediatric pulmonary diseases published globally between 2010 and 2020. We searched PubMed, Web of Science, MEDLINE, Paediatric Economic Database Evaluation (PEDE), and the Cochrane library. EEs included were specific to paediatric pulmonary diseases in a hospital setting and of children aged from zero to six years old. We extracted data items guided by the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. We collected qualitative and quantitative data which we analysed in Microsoft Excel and R Software. Results 22 studies met the inclusion criteria. Seven of the articles were cost-effectiveness analyses, five cost-utility analyses, two cost-minimisation analyses, and eight cost analyses. Fourteen studies were conducted in high-income countries, eight in low-middle-income countries (LMICs). Ten studies were on asthma, nine on pneumonia, two on asthma and pneumonia, and one on tuberculosis. Quality assessment of the articles revealed some methodological inconsistencies across the articles. Conclusion Fewer EEs were conducted in LMICs, yet children from these countries are disproportionately affected by pulmonary diseases. Developing standardised methods for EEs and conducting more EEs and for paediatric pulmonary diseases in LMICs could allow for more evidence-based decision-making. DA - 2021_ DB - OpenUCT DP - University of Cape Town KW - paediatric pulmonary disease KW - economic evaluation KW - systematic review LK - https://open.uct.ac.za PY - 2021 T1 - Systematic review of economic evaluations for paediatric pulmonary diseases TI - Systematic review of economic evaluations for paediatric pulmonary diseases UR - http://hdl.handle.net/11427/33600 ER - en_ZA
dc.identifier.urihttp://hdl.handle.net/11427/33600
dc.identifier.vancouvercitationChitando M. Systematic review of economic evaluations for paediatric pulmonary diseases. []. ,Faculty of Health Sciences ,Health Economics Unit, 2021 [cited yyyy month dd]. Available from: http://hdl.handle.net/11427/33600en_ZA
dc.language.rfc3066eng
dc.publisher.departmentHealth Economics Unit
dc.publisher.facultyFaculty of Health Sciences
dc.subjectpaediatric pulmonary disease
dc.subjecteconomic evaluation
dc.subjectsystematic review
dc.titleSystematic review of economic evaluations for paediatric pulmonary diseases
dc.typeMaster Thesis
dc.type.qualificationlevelMasters
dc.type.qualificationlevelMPH
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
thesis_hsf_2021_chitando mutsawashe.pdf
Size:
2.17 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Masters